Clinical characteristics of response to fluoxetine treatment of obsessive-compulsive disorder

Journal of Clinical Psychopharmacology

Volumn 18, Issue 3, 1998, Pages 185-192

  Ackerman, Deborah L ^a   Greenland, Sander ^a   Bystritsky, Alexander ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE;

ADULT; ARTICLE; CLINICAL TRIAL; COMPULSION; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSESSION; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; RATING SCALE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PROGNOSIS; SEROTONIN UPTAKE INHIBITORS;

EID: 0031831760     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199806000-00002     Document Type: Article

References (29)

1. Jenike MA, Baer L, Greist JH. Clomipramine versus fluoxetine in obsessive-compulsive disorder: a retrospective comparison of side effects and efficacy. J Clin Psychopharmacol 1990;10: 122-4.
2. Davis J, Israni T, Janicak P, Wang Z, Holland D. A meta-analysis of drug efficacy studies in obsessive-compulsive disorder [abstract]. Biol Psychiatry 1991;29:444S.
3. Stein DJ, Spadaccini E, Hollander E. Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. Int Clin Psychopharmacol 1995;10:11-8.
4. Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC. Efficacy and tolerability of serotonin transport inhibitors. Arch Gen Psychiatry 1995;52:53-60.
5. Piccinelli M, Pini S, Bellantuono C, Wilkinson G. Efficacy of drug treatment in obsessive-compulsive disorder: a meta-analytic review. Br J Psychiatry 1995;166:424-43.
6. Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ, Murphy DL. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder: behavioral and biological results. Arch Gen Psychiatry 1990;47: 926-32.
7. Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ. Fluvoxamine versus clomipramine in the treatment of obsessive-compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. J Clin Psychiatry 1994; 55:301-54.
8. Koran LM, McElroy SL, Davidson JR, Rasmussen SA, Hollander E, Jenike MA. Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. J Clin Psychopharmacol 1996;16:121-9.
9. AuBuchon PG, Malatesta VJ. Obsessive-compulsive patients with comorbid personality disorder: associated problems and response to a comprehensive behavior therapy. J Clin Psychiatry 1994;55:448-53.
10. Baer L, Jenike MA, Black DW, Treece C, Rosenfield R, Greist J. Effect of axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49:862-6.
11. Carrasco JL, Hollander E, Schneier FR, Liebowitz MR. Treatment outcome of obsessive-compulsive disorder with comorbid social phobia. J Clin Psychiatry 1992;53:387-91.
12. Dar R, Greist JH. Behavior therapy for obsessive-compulsive disorder. Psychiatr Clin North Am 1992;15:885-94.
13. Jenike MA, Baer L, Minichiello WE, Schwartz CE, Carey RJ Jr. Concomitant obsessive-compulsive disorder and schizotypal personality disorder. Am J Psychiatry 1986;143:530-2.
14. McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. J Clin Psychopharmacol 1993;13:354-8.
15. Orloff LM, Battle MA, Baer L, Ivanjack L, Pettit AR, Buttolph ML, Jenike MA. Long-term follow-up of 85 patients with obsessive-compulsive disorder. Am J Psychiatry 1994;151:441-2.
16. Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G. Predictors of drug treatment response in obsessive-compulsive disorder. J Clin Psychiatry 1995;56:368-73.
17. Alarcon RD, Libb JW, Spitler D. A predictive study of obsessive-compulsive disorder response to clomipramine. J Clin Psychopharmacol 1993;13:210-3.
18. Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1991;48:730-8.
19. Ackerman DL, Greenland S, Bystritsky A, Morgenstern H, Katz RJ. Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine. J Clin Psychopharmacol 1994;14:247-54.
20. Capstick N, Seldrup J. Phenomenological aspects of obsessional patients treated with clomipramine. Br J Psychiatry 1973;122: 719-20.
21. Marks IM, Stern RS, Mawson D, Cobb J, McDonald R. Clomipramine and exposure for obsessive-compulsive rituals: i. Br J Psychiatry 1980;136:1-25.
22. Insel TR, Murphy DL, Cohen RM, Alterman I, Kilts C, Linnoila M. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. Arch Gen Psychiatry 1983;40:605-12.
23. Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellstrom B, Linnoila M. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study. Arch Gen Psychiatry 1985;42:977-83.
24. Goodman WK, Kozak MJ, Liebowitz M, White KL. Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial. Int Clin Psychopharmacol 1996;11:21-9.
25. Tollefson GD, Rampey AH, Potvin JH, Jenike MA, Rush JA, Dominguez RA, Koran LM, Shear MK, Goodman W, Genduso LA. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1994;51:559-67.
26. Katz RJ, DeVeaugh-Geiss J. The antiobsessional effects of clomipramine do not require concomitant affective disorder. Psychiatry Res 1990;31:121-9.
27. Tollefson GD, Birkett M, Koran L, Genduso L. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine. J Clin Psychiatry 1994;55[suppl]:69-76.
28. Rasmussen SA, Tsuang RT. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry 1986;143:317-22.
29. Demal U, Lenz G, Mayrhofer A, Zapotoczky H-G, Zitterl W. Obsessive-compulsive disorder and depression. Psychopathology 1993;26:145-50.